Metagenomics Reveals a Core Macrolide Resistome Related to Microbiota in Chronic Respiratory Disease

From BugSigDB
Needs review
study design
Citation
PMID PubMed identifier for scientific articles.
DOI Digital object identifier for electronic documents.
URI
Authors
Mac Aogáin M, Lau KJX, Cai Z, Kumar Narayana J, Purbojati RW, Drautz-Moses DI, Gaultier NE, Jaggi TK, Tiew PY, Ong TH, Siyue Koh M, Lim Yick Hou A, Abisheganaden JA, Tsaneva-Atanasova K, Schuster SC, Chotirmall SH
Journal
American journal of respiratory and critical care medicine
Year
2020
Keywords:
antimicrobial resistance, macrolides, metagenomics, resistome, respiratory disease
Rationale: Long-term antibiotic use for managing chronic respiratory disease is increasing; however, the role of the airway resistome and its relationship to host microbiomes remains unknown.Objectives: To evaluate airway resistomes and relate them to host and environmental microbiomes using ultradeep metagenomic shotgun sequencing.Methods: Airway specimens from 85 individuals with and without chronic respiratory disease (severe asthma, chronic obstructive pulmonary disease, and bronchiectasis) were subjected to metagenomic sequencing to an average depth exceeding 20 million reads. Respiratory and device-associated microbiomes were evaluated on the basis of taxonomical classification and functional annotation including the Comprehensive Antibiotic Resistance Database to determine airway resistomes. Co-occurrence networks of gene-microbe association were constructed to determine potential microbial sources of the airway resistome. Paired patient-inhaler metagenomes were compared (n = 31) to assess for the presence of airway-environment overlap in microbiomes and/or resistomes.Measurements and Main Results: Airway metagenomes exhibit taxonomic and metabolic diversity and distinct antimicrobial resistance patterns. A "core" airway resistome dominated by macrolide but with high prevalence of β-lactam, fluoroquinolone, and tetracycline resistance genes exists and is independent of disease status or antibiotic exposure. Streptococcus and Actinomyces are key potential microbial reservoirs of macrolide resistance including the ermX, ermF, and msrD genes. Significant patient-inhaler overlap in airway microbiomes and their resistomes is identified where the latter may be a proxy for airway microbiome assessment in chronic respiratory disease.Conclusions: Metagenomic analysis of the airway reveals a core macrolide resistome harbored by the host microbiome.

Experiment 1


Needs review

Curated date: 2023/10/22

Curator: ChiomaBlessing

Revision editor(s): WikiWorks, Peace Sandy, ChiomaBlessing, KateRasheed

Subjects

Location of subjects
Singapore
Host species Species from which microbiome was sampled. Contact us to have more species added.
Homo sapiens
Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
Sputum

Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
Group 0 name Corresponds to the control (unexposed) group for case-control studies
Non-diseased/ healthy individuals (ND)
Group 1 name Corresponds to the case (exposed) group for case-control studies
Diseased individuals (D)
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
Patients with a range of chronic respiratory disease states (severe asthma, chronic obstructive pulmonary disease- COPD, and bronchiectasis)
Group 0 sample size Number of subjects in the control (unexposed) group
13
Group 1 sample size Number of subjects in the case (exposed) group
41

Lab analysis

Sequencing type
WMS
16S variable region One or more hypervariable region(s) of the bacterial 16S gene
Not specified
Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
Illumina

Statistical Analysis

Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
relative abundances
Statistical test
LEfSe
Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
0.05
MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
No
LDA Score above Threshold for the linear discriminant analysis (LDA) score for studies using the popular LEfSe tool
2

Alpha Diversity

Shannon Estimator of species richness and species evenness: more weight on species richness
increased
Chao1 Abundance-based estimator of species richness
decreased
Simpson Estimator of species richness and species evenness: more weight on species evenness
unchanged

Signature 1

Needs review

Curated date: 2023/10/22

Curator: ChiomaBlessing

Revision editor(s): ChiomaBlessing, WikiWorks

Source: Supplemental. fig. E3D and Supplemental fig. E3E

Description: Differential microbial abundance between diseased (D) and nondiseased (ND)/ healthy individuals

Abundance in Group 1: increased abundance in Diseased individuals (D)

NCBI Quality ControlLinks
Arachnia
Bifidobacterium
Corynebacterium
Escherichia
Haemophilus
Klebsiella
Paenibacillus
Pseudomonas
Psychrobacter
Tannerella
Rothia mucilaginosa

Revision editor(s): ChiomaBlessing, WikiWorks

Signature 2

Needs review

Curated date: 2023/10/22

Curator: ChiomaBlessing

Revision editor(s): ChiomaBlessing, WikiWorks

Source: Supplemental. fig. E3D and Supplemental fig. E3E

Description: Differential microbial abundance between diseased (D) and nondiseased (ND)/ healthy individuals

Abundance in Group 1: decreased abundance in Diseased individuals (D)

NCBI Quality ControlLinks
Parvimonas
Mycoplasma
Selenomonas
Dialister
Leptotrichia
Mogibacterium
Atopobium
Aggregatibacter
Solobacterium
Olsenella
Catonella
Lautropia
Actinobaculum
Campylobacter
Lachnoanaerobaculum
Peptostreptococcus
Alloprevotella
Clostridium
Desulfomicrobium
Fusobacterium
Treponema
Prevotella

Revision editor(s): ChiomaBlessing, WikiWorks